ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 687305 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 687305; 2) Community: the network communities that were significantly associated with the response to NSC 687305; 3) Molecule: the relationships between components within communities and NSC 687305; 4) MDR: the compounds that were significantly associated with the NSC 687305.

NSC Compound Enrichment Correlation
NSC 381866 BAFILOMYCIN DERIV. 0.0284045326811618 0.30765836
NSC 606698 Rapamycin prodrug, Mono-(28)-N,N-dimethylglycinate-, methanesulfonic acid salt 0.0284045326811618 -0.1272454
NSC 632608 Diammine-1,7,10,16-tetraoxa-4,13-diazacyclooctadecane- platinum(II)dichloride 0.0284045326811618 0.096861158
NSC 633782 Simvastatin 0.0284045326811618 -0.2420744
NSC 637459 Macrocalyxoformin B (Rabdosia diterpenoids) 0.0284045326811618 0.24878617
NSC 638199 Null 0.0284045326811618 0.34758828
NSC 639366 1-[[3'-(Diethylamino)-2'-hydroxypropyl]amino]-4- [(2'',3''-epoxypropyl)-amino-9,10-anthracenedione Fumaric Acid 0.0284045326811618 0.46093709
NSC 642915 Null 0.0284045326811618 0.34685902
NSC 665534 5-Quinolinesulfonic acid, 7,7'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)iminocarbonyl]]bis[8-hydroxy-, tetrasodium salt 0.0284045326811618 0.41306221
NSC 667047 2-propenyl estradiol 0.0284045326811618 0.2625736
Total:83  Current:53    [First] [Prev] [Next] [Last]